Skip to content

Prof. Parisi Vincenzo

Ophthalmologist, Researcher
Head of the Research Unit (RU) for Neurophysiology of Vision and Neuro-Ophthalmology, Head of the Clinical and Research Center for Neuro-Ophthalmology, Genetic and Rare Diseases.
Parisi Vincenzo
Specialization: Ophthalmology
Professional register: Registered with the Provincial Register of Surgeons and Physicians of Rome (Rome Provincial Order), Registration No. 38147, dated March 23, 1987.

Opera presso IRCCS Fondazione G.B. Bietti nelle sedi di Via Livenza, 3 e Via di Santo Stefano Rotondo 6, presso Presidio Ospedaliero Britannico, Roma . 

Scientific Publications: PubMed

LinkedIn Profile: Vincenzo Parisi

 

  • 1986: Degree in Medicine and Surgery from “La Sapienza” University of Rome, with a final grade of 110/110 cum laude
  • 1990: Specialization in Ophthalmology from “Tor Vergata” University of Rome, with a final grade of 50/50 cum laude
  • 1989–1993: Consultant for the Medico-Legal Institute (IML) of the Italian Air Force in Rome.
  • 1992–2002: Visiting Ophthalmologist at the Ophthalmology Clinic of “Tor Vergata” University, directed by Prof. Massimo G. Bucci, where he/she contributed to Clinical, Surgical, Teaching, and Research activities.
  • 1999–2003: Fellow of the Fatebenefratelli Association for Research (AFaR).
  • 1998: Invited by Prof. Mario Stirpe (President) and Prof. Massimo G. Bucci (Scientific Director) to take part in the clinical-scientific activities of the Fondazione G.B. Bietti – ONLUS (Foundation for the Study and Research in Ophthalmology G.B. Bietti – Non-profit organization).
  • 2001–2005: Appointed “Editor” by the Bietti Foundation (Responsible for evaluating research activities intended for publication in international journals).
  • 2005–2017: Member of the Scientific Committee and Head of the Research Unit for “Neurophysiology of Vision and Neuro-Ophthalmology,” coinciding with the year the Fondazione G.B. Bietti was recognized as a Scientific Institute for Research and Healthcare (IRCCS).
  • 1999–2010: Teaching assignment in Neuro-Ophthalmology at the Second School of Specialization in Neurology, “La Sapienza” University of Rome.
  • 2002–2010: Adjunct Professor of Neuro-Ophthalmology at the School of Specialization in Neurology, “Tor Vergata” University of Rome.
  • 2017–2019: Teaching assignment in Neurophysiology of Vision for the First-Level Master’s Program in Legal Ophthalmology, “La Sapienza” University of Rome.
  • Italian Ophthalmological Society
  • Italian Society of Clinical Neurophysiology
  • Italian Glaucoma Study Association
  • Italian Society of Neuro-Ophthalmology
  • Italian Retina Society The Association for Research in Vision and Ophthalmology (ARVO)
  • New York Academy of Sciences International Society for Clinical Electrophysiology of Vision (ISCEV)
  • Founding Member of the Interdisciplinary Neuroprotection Group

Principal Investigator – Targeted Research Projects (Ministry of Health)

  • 2005–2007: Scientific Lead of the Targeted Research Project, Ministry of Health: “Potential therapeutic role of Nerve Growth Factor in glaucoma: studies in an animal model and in humans.”
  • 2007–2010: Scientific Lead of the Targeted Research Project, Ministry of Health: “Leber’s optic neuropathy: from the early diagnosis to the rehabilitation.”
  • 2014–2017: Scientific Lead of the Targeted Research Project, Ministry of Health: “Morphofunctional visual pathways evaluation in multiple sclerosis: possible identification of neurodegenerative biomarkers.”

Principal Investigator – Italian Medicines Agency (AIFA) Projects

  • 2012: Scientific Lead of the AIFA project: “Evaluation of potential neuroprotective action of minocycline in addition to topical hypotensive therapy for the maintenance of functional visual impairment in patients with Glaucoma.”

Principal Investigator – Clinical Trials

  • 1996–1998: Scientific Lead of the Project: “Clinical study for the evaluation of the efficacy of intramuscularly administered Citicoline in the maintenance of retinal function and post-retinal nerve conduction in patients with chronic simple glaucoma.”
  • 1996–1998: Scientific Lead of the Project: “Clinical study for the evaluation of the efficacy of Nicergoline in the maintenance of retinal function and post-retinal nerve conduction in patients with chronic simple glaucoma.”
  • 2000–2002: Scientific Lead of the Multicenter Project: “Clinical study for the evaluation of the efficacy of intramuscularly administered Citicoline versus orally administered Citicoline in the maintenance of retinal function and post-retinal nerve conduction in patients with chronic simple glaucoma.”
  • 2006–2007: Scientific Lead of the Multicenter Project: “Clinical study for the evaluation of the efficacy of a tablet-based food supplement containing Epigallocatechin-gallate in the maintenance of retinal function and post-retinal nerve conduction in patients with chronic simple glaucoma.”
  • 2008–2012: Scientific Lead of the Multicenter Project: “Effect of an ophthalmic solution based on coenzyme Q10 and vitamin E TPGS on retinal function in patients with glaucomatous optic neuropathy: a spontaneous pilot study including electroretinography and visual evoked potentials. Multicenter study.”
  • 2009–2013: Scientific Lead of the Multicenter Project: “Effects of L-Acetylcarnitine administration on nerve conduction along the optic pathways in patients with Leber’s Hereditary Optic Neuropathy.”
  • 2012–2014: Scientific Lead of the Multicenter Project: “Evaluation of the potential neuroprotective action of Citicoline eye drops in addition to topical hypotensive therapy for the maintenance of visual functional deficit in patients with glaucoma.”
  • 2017–2019: Scientific Lead of the project: “Neuroprotection and Neuro-enhancement in a model of optic nerve neurodegeneration (Non-arteritic Ischemic Neuritis): study of morpho-functional variations in relation to treatment with oral Citicoline solution.”
  • 2018–2019: Co-Scientific Lead of the project: “Evaluation of the effect on visual function of Citicoline in liposomal ocular solution, in addition to topical hypotensive therapy in patients with glaucoma. Pre-market clinical investigation.”
  • 2018–2019: Co-Scientific Lead of the project: “Evaluation of macular function and related changes in visual perception and retinal morphology after 6 months of use of a tablet-based food supplement [Ganoderma lucidum (Reishi), Calendula Officinalis, Lutepure-Marigold (5% Lutein and 1% Zeaxanthin), Bilberry, Rutin, Alpha-lipoic acid, Bromelain, NAC, Vitamin C, B9, B12, D3, Selenium, Zinc, and Copper] called MACUPREV, in patients with dry type age-related macular degeneration.”
  • 2021: Scientific Lead of the project: “Modulation of neuronal connectivity along the optic pathways in glaucomatous patients through treatment with oral Citicoline solution: a multimodal morpho-functional study.”
  • Ecco la traduzione degli incarichi di revisione (reviewer):
  • Since June 1997: Reviewer for Clinical Neurophysiology.
  • Since 1999: Reviewer for Investigative Ophthalmology and Visual Science.
  • Since 2000: Reviewer for Documenta Ophthalmologica and Ophthalmic and Physiological Optics.
  • Since 2002: Reviewer for Current Eye Research, European Journal of Ophthalmology, and Pathophysiological Optics (Ottica Fisiopatologica).
  • Since 2004: Reviewer for Archives of Ophthalmology, Brain, and Ophthalmology.
  • Since 2006: Reviewer for Vision Research, European Journal of Neurology, and British Journal of Ophthalmology.
  • Since 2007: Reviewer for Expert Review of Ophthalmology.
  • Since 2013: Reviewer for Journal of Translational Medicine.
  • Since 2014: Reviewer for Experimental Eye Research.
  • Since 2016: Reviewer for Journal of Glaucoma and Journal of Alzheimer’s Disease.
  • Since 2020: Reviewer for Scientific Reports and Frontiers.
  • 1999–2017: Guest Editorial Board Member for Investigative Ophthalmology and Visual Science
  • 2016–2017: Editorial Board Member for Ophthalmology @Point of Care
  • 2020: Editorial Board Member for Journal of Clinical Medicine
  • 1991: Winner of a CNR scholarship for “Research in the field of disciplines related to the national committee for technological research and innovation.”
  • December 1993: Winner of a scholarship from the International Fatebenefratelli Foundation for “Research in the field of retinal pathophysiology.”
  • January 1998: Publication of biography in WHO’S WHO IN SCIENCE AND ENGINEERING with the following motivation: “has demonstrated notable knowledge and recognized appreciation in his/her field of scientific application that have significantly contributed to the improvement of contemporary society.”
  • 1998: Winner of the Italian Ophthalmological Society (SOI) Award for Clinical Research.
  • 1999–2003: Winner of five scholarships from the International Fatebenefratelli Foundation for “Electrophysiology of Vision” and “Vision.”
  • 2007, 2008, and 2010: Appointed “Moderator” for the “Morphology, Electrophysiology and Visual Function” section by the Association for Research in Vision and Ophthalmology (ARVO).
Skip to content